Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


RU-486 Lower-Dose, Home-Administered Misoprostol Being Evaluated

Executive Summary

The Population Council is planning a trial to demonstrate that a 200 mg dose of the abortifacient Mifeprex is effective and that the misoprostol component of the regimen can be safely used at home.

You may also be interested in...

Pharmacia VP Friedman Is Among PhRMA Favorites For FDA Commissioner

Pharmacia Senior VP Michael Friedman's recent letter to the New England Journal of Medicine regarding the use of Cytotec (misoprostol) in pregnant women should help continue his candidacy to return to FDA as commissioner.

Pharmacia Cytotec Use For Labor Induction Reaffirmed By ACOG

The American College of Obstetricians & Gynecologists is reaffirming its guidelines supporting the use of Pharmacia/Searle's Cytotec (misoprostol) for the induction of labor.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts